title: Endogenous murine leukemia virus DNA sequences in murine cell lines: implications for gene therapy safety testing by PCR.
abstract: Safety testing for replication-competent retrovirus (RCR) is an important requirement in gene transfer clinical trials using retroviral vectors. A sensitive polymerase chain reaction (PCR) method is one approach to RCR detection. Only in the presence of RCR will the pol-env encoding sequences, necessary for viral replication and packaging, be amplified from proviral DNA in infected indicator cells. To avoid false-positive results in this assay it is crucial that indicator cell lines are free of endogenous retroviral sequences that could also be amplified with pol-env PCR primers. We screened candidate murine indicator cell lines and determined that while Mus dunni is free of detectable pol-env sequences, endogenous retroviral sequences do indeed exist in several cell lines and lead to false-positive results in the PCR assay for RCR. Furthermore, these endogenous retroviral sequences are expressed as RNA transcripts in NIH 3T3 and SC-1 cell lines, as determined by PCR amplification of cDNA but, nevertheless, do not give rise to replication-competent particles. We recognize the potential for murine cell lines to undergo spontaneous rearrangements of endogenous viral sequences in culture and give rise to recombinants containing newly acquired contiguous pol-env sequences. Indicator cell lines should thus be carefully selected and monitored on an ongoing basis when used in safety testing using PCR approaches for the detection of RCR.
authors.affiliation: Faculty of Medicine, Queen's University, Kingston, Ontario, Canada.
authors.forename: D S
authors.initials: DS
authors.lastname: Allan
authors.forename: A
authors.initials: A
authors.lastname: De Koven
authors.forename: A
authors.initials: A
authors.lastname: Wild
authors.forename: S
authors.initials: S
authors.lastname: Kamel-Reid
authors.forename: I D
authors.initials: ID
authors.lastname: Dubé
mesh_terms: D016475:3T3 Cells / Q000821:virology; D000818:Animals; D004279:DNA, Viral / Q000235:genetics*; D015752:Genes, env; D015751:Genes, pol; D015316:Genetic Therapy / Q000009:adverse effects / Q000379:methods*; D009052:Leukemia Virus, Murine / Q000235:genetics* / Q000502:physiology; D051379:Mice; D016133:Polymerase Chain Reaction / Q000379:methods*; D012190:Retroviridae / Q000235:genetics / Q000502:physiology; D014158:Transcription, Genetic; D014779:Virus Replication
chemical_list: D004279:DNA, Viral